REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Iyarkai - Pharma S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Health and Personal Care Stores | Pharmacies and Drug Stores
Full name: Iyarkai - Pharma S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Iyarkai - Pharma S.A. is based in Ecuador. The head office is in Samborondon. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on March 12, 2020. There are currently 4 (2023) people employed by Iyarkai - Pharma S.A.. The company’s latest financial report indicates a net sales revenue drop of 20.88% in 2023. Its total assets decreased by 47.42% over the same period. The net profit margin of Iyarkai - Pharma S.A. increased by 1.38% in 2023.

Headquarters
Ciudad Celeste Villa 8
Samborondon; Guayas;

Contact Details: Purchase the Iyarkai - Pharma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Iyarkai - Pharma S.A. report to view the information.
Outstanding Shares:
Purchase the Iyarkai - Pharma S.A. report to view the information.
Registered Capital:
Purchase the Iyarkai - Pharma S.A. report to view the information.
Incorporation Date:
March 12, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Iyarkai - Pharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-20.88%▼
Total operating revenue
-20.86%▼
Net Profit (Loss) for the Period
16479.58%▲
Total assets
-47.42%▼
Total equity
80.82%▲
Net Profit Margin
1.38%▲
Return on Equity (ROE)
39.79%▲
Quick Ratio
0.1%▲
Cash Ratio
-0.05%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo